MANCUSO, Katia
 Distribuzione geografica
Continente #
AS - Asia 63
EU - Europa 59
NA - Nord America 53
SA - Sud America 21
OC - Oceania 3
Totale 199
Nazione #
US - Stati Uniti d'America 38
CN - Cina 30
IT - Italia 25
AR - Argentina 17
SG - Singapore 16
CA - Canada 10
JP - Giappone 9
DE - Germania 7
RU - Federazione Russa 6
DK - Danimarca 4
FR - Francia 4
AU - Australia 3
CU - Cuba 3
NL - Olanda 3
NO - Norvegia 3
BR - Brasile 2
CO - Colombia 2
ES - Italia 2
FI - Finlandia 2
ID - Indonesia 2
KR - Corea 2
MX - Messico 2
RS - Serbia 2
TR - Turchia 2
GB - Regno Unito 1
IR - Iran 1
KW - Kuwait 1
Totale 199
Città #
Singapore 12
Montreal 10
La Plata 9
Santa Clara 8
Beijing 7
Milan 7
Denver 5
Turin 5
Bethesda 4
Foggia 4
Buenos Aires 3
Camden 3
Havana 3
Melbourne 3
Modena 3
Munich 3
Ningbo 3
Oslo 3
Paraná 3
Tokyo 3
Wuhan 3
Amsterdam 2
Ankara 2
Barcelona 2
Belgrade 2
Columbus 2
Dresden 2
Hammelburg 2
Hobro 2
Jakarta 2
Lappeenranta 2
Lincoln 2
Medellín 2
Naples 2
New York 2
Paris 2
Port Chester 2
Rosario 2
Salvador 2
Seattle 2
Seoul 2
Shaoxing 2
Shenyang 2
Shizuoka 2
Boardman 1
Cabriès 1
Chengdu 1
Copenhagen 1
Florence 1
Kuwait City 1
London 1
Maebashi 1
Montesilvano Marina 1
Moscow 1
Odense 1
Perugia 1
Pisa 1
Piscataway 1
Shanghai 1
Takasaki 1
Yekaterinburg 1
Totale 167
Nome #
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study 159
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 24
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients 20
Totale 203
Categoria #
all - tutte 621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 621


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202463 0 0 0 0 0 5 4 1 0 2 29 22
2024/2025140 40 28 31 28 13 0 0 0 0 0 0 0
Totale 203